How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
- 4 November 2024
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 19 (24)
Abstract
Fragment‐based drug discovery (FBDD) is a crucial strategy for developing new drugs that have been applied to diverse targets, from neglected infectious diseases to cancer. With at least seven drugs already launched to the market, this approach has gained interest in both academics and industry in the last 20 years. FBDD relies on screening small libraries with about 1000–2000 compounds of low molecular weight (about 300 Da) using several biophysical methods. Because of the reduced size of the compounds, the chemical space and diversity can be better explored than large libraries used in high throughput screenings. This review summarises the most common biophysical techniques used in fragment screening and orthogonal validation. We also explore the advantages and drawbacks of the different biophysical techniques and examples of applications and strategies.Keywords
This publication has 154 references indexed in Scilit:
- Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**Angewandte Chemie International Edition, 2023
- Binding of Glycans to the SARS CoV‐2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and SelectivityChemistry – A European Journal, 2022
- Native Mass Spectrometry‐Guided Screening Identifies Hit Fragments for HOP‐HSP90 PPI Inhibition**ChemBioChem, 2022
- PI by NMR: Probing CH–π Interactions in Protein–Ligand Complexes by NMR SpectroscopyAngewandte Chemie, 2020
- Establishing Trypanosoma cruzi farnesyl pyrophosphate synthase as a viable target for biosensor driven fragment‐based lead discoveryProtein Science, 2020
- Fast NMR Methods for Measuring in the Direct and/or Competition Mode the Dissociation Constants of Chemical Fragments Interacting with a ReceptorChemMedChem, 2019
- Fragment‐Based Phenotypic Lead Discovery: Cell‐Based Assay to Target LeishmaniasisChemMedChem, 2018
- Investigating Protein–Ligand Interactions by Solution Nuclear Magnetic Resonance SpectroscopyChemphyschem, 2018
- Differential Epitope Mapping by STD NMR Spectroscopy To Reveal the Nature of Protein–Ligand ContactsAngewandte Chemie International Edition, 2017
- Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate SynthetaseAngewandte Chemie International Edition, 2009